Computational Evaluation of Selectivity of Inhibition of Muscarinic Receptors M1-M4
- 1 July 2018
- journal article
- Published by Institute of Biochemistry in Biomedical Chemistry: Research and Methods
- Vol. 1 (3), e00072
- https://doi.org/10.18097/bmcrm00072
Abstract
A set of models for preliminary estimation of the inhibition constant values of potential ligands for the 4 acetylcholine muscarinic receptors M1-M4 was developed. The study uses an information about three-dimensional structure of human M1, M2 and M4 receptors, as well as the M3 receptor model, constructed by homology based on the structure of the rat M3 receptor. The Ki values for 42 compounds were obtained from the sources. Modeling of “protein-ligand” complexes was performed using molecular docking and molecular dynamics procedures. The component energy characteristics of the complexes were calculated from data obtained from simulation of molecular dynamics by the MM-PBSA/MM-GBSA methods. These characteristics were used as independent variables to construct the linear regression equations for pKi value predicting. The equations obtained for each receptors allow us to predict pKi with an average accuracy of 0.65 logarithmic units.Keywords
This publication has 14 references indexed in Scilit:
- Prediction of selective inhibition of neuraminidase from various influenza virus strains by potential inhibitorsBiomeditsinskaya Khimiya, 2016
- Crystal structures of the M1 and M4 muscarinic acetylcholine receptorsNature, 2016
- Structure and dynamics of the M3 muscarinic acetylcholine receptorNature, 2012
- Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonistNature, 2012
- Muscarinic acetylcholine receptors as CNS drug targetsPharmacology & Therapeutics, 2008
- Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic functionAutonomic & Autacoid Pharmacology, 2006
- The Protein Data BankNucleic Acids Research, 2000
- Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactionsJournal of Computational Chemistry, 1996
- The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivoLife Sciences, 1993
- Knowledge‐based protein modelling and designJBIC Journal of Biological Inorganic Chemistry, 1988